UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
AMN Healthcare
AMN
$1.4B
| $2.87M | ﹤0.01% |
138,769
+30,747
| +28% | +$639K |
|
1977
National Health Investors
NHI
$3.65B
| $2.85M | ﹤0.01% |
40,667
-209,270
| -84% | -$15.3M |
|
|
AIOT
1978
PowerFleet Inc
AIOT
$592M
| $2.85M | ﹤0.01% |
660,906
-7,580
| -1% | -$37.4K |
|
|
MAG
1979
DELISTED
MAG Silver
MAG
| $2.85M | ﹤0.01% |
134,664
+15,442
| +13% | +$274K |
|
|
ODP
1980
DELISTED
ODP
ODP
| $2.84M | ﹤0.01% |
156,882
+36,868
| +31% | +$578K |
|
1981
Ivanhoe Electric
IE
$1.74B
| $2.84M | ﹤0.01% |
313,377
+35,305
| +13% | +$245K |
|
1982
United States Lime & Minerals
USLM
$3.44B
| $2.84M | ﹤0.01% |
28,445
+10,510
| +59% | +$1.03M |
|
1983
Bitdeer Technologies
BTDR
$2.65B
| $2.84M | ﹤0.01% |
247,010
+123,972
| +101% | +$1.43M |
|
1984
Mission Produce
AVO
$1.17B
| $2.83M | ﹤0.01% |
241,042
+77,738
| +48% | +$842K |
|
|
SAND
1985
DELISTED
Sandstorm Gold
SAND
| $2.82M | ﹤0.01% |
300,486
-38,798
| -11% | -$332K |
|
|
THR
1986
DELISTED
Thermon Group Holdings
THR
| $2.81M | ﹤0.01% |
100,106
+29,259
| +41% | +$793K |
|
1987
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
| $2.81M | ﹤0.01% |
15,460
-51,232
| -77% | -$8.84M |
|
1988
BlackBerry
BB
$5.26B
| $2.81M | ﹤0.01% |
613,009
-210,813
| -26% | -$795K |
|
1989
Novavax
NVAX
$1.31B
| $2.81M | ﹤0.01% |
445,587
+132,798
| +42% | +$879K |
|
1990
Collegium Pharmaceutical
COLL
$956M
| $2.8M | ﹤0.01% |
94,787
+23,773
| +33% | +$678K |
|
1991
Dyne Therapeutics
DYN
$4.9B
| $2.8M | ﹤0.01% |
293,644
+135,853
| +86% | +$1.5M |
|
1992
Agilon Health
AGL
$1.6B
| $2.78M | ﹤0.01% |
48,408
+17,354
| +56% | +$1.39M |
|
|
RAPP
1993
Rapport Therapeutics
RAPP
$2.18B
| $2.77M | ﹤0.01% |
243,880
+40,638
| +20% | +$431K |
|
|
OLO
1994
DELISTED
Olo Inc
OLO
| $2.77M | ﹤0.01% |
311,408
+146,235
| +89% | +$1.13M |
|
1995
Southside Bancshares
SBSI
$967M
| $2.76M | ﹤0.01% |
93,913
+23,536
| +33% | +$667K |
|
1996
Applied Optoelectronics
AAOI
$11.5B
| $2.76M | ﹤0.01% |
107,468
+40,274
| +60% | +$652K |
|
1997
Helen of Troy
HELE
$693M
| $2.76M | ﹤0.01% |
97,172
+22,863
| +31% | +$702K |
|
1998
Amalgamated Financial
AMAL
$1.49B
| $2.75M | ﹤0.01% |
88,210
+23,100
| +35% | +$677K |
|
1999
Ecovyst
ECVT
$1.14B
| $2.75M | ﹤0.01% |
333,959
+85,228
| +34% | +$598K |
|
2000
Harrow
HROW
$1.51B
| $2.75M | ﹤0.01% |
89,917
+25,776
| +40% | +$693K |
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.